Mapmygenome acquires dnaPower to expand North American footprint
The story in brief
Mapmygenome acquired dnaPower Inc on October 21, 2026, to expand its North American operations. A centralised Vancouver processing hub will operate under CAP-accredited and ISO-certified protocols. The combined platform will offer DNA testing, gut microbiome profiling, and other precision health services across Canada and the United States.